Compare BY & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BY | AXGN |
|---|---|---|
| Founded | 1914 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2017 | N/A |
| Metric | BY | AXGN |
|---|---|---|
| Price | $31.65 | $31.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $33.67 | $33.67 |
| AVG Volume (30 Days) | 174.8K | ★ 701.5K |
| Earning Date | 01-22-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | ★ 1.54 | N/A |
| EPS | ★ 2.80 | N/A |
| Revenue | ★ $400,663,000.00 | $214,709,000.00 |
| Revenue This Year | $19.64 | $21.87 |
| Revenue Next Year | $3.98 | $15.69 |
| P/E Ratio | $11.28 | ★ N/A |
| Revenue Growth | 7.23 | ★ 18.72 |
| 52 Week Low | $22.63 | $9.22 |
| 52 Week High | $31.78 | $34.71 |
| Indicator | BY | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 66.00 | 52.46 |
| Support Level | $30.07 | $30.52 |
| Resistance Level | $31.15 | $33.57 |
| Average True Range (ATR) | 0.71 | 1.60 |
| MACD | 0.14 | -0.23 |
| Stochastic Oscillator | 85.86 | 37.96 |
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.